The European Commission is encouraging member countries to work together more effectively on assessing and paying for new therapies and health technologies with a proposal it published Tuesday.
The 18-page proposed rule sets out to establish practices to ensure that EU-level assessments of new products are efficient and done with the relevant expertise. The EC is accepting comments on the draft rule until April 5.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.